Patrick Peavy, MD
Orthopaedic Surgery · Birmingham, ALNPI 1063823094
Payments from drug & device makers
Across 70 payments — averaging $119.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$3K
- ALON Medical Technology$2K
- Johnson & Johnson$701
- Linkbio Corp$619
- Conformis, Inc.$453
- Stryker$187
- plus $654 from 11 others
What the payments were for
- Travel & lodging$2,25127%
- Food & beverage$3,62543%
- Education$2,48630%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 25 | $3,433 |
| ALON Medical Technology | 3 | $2,315 |
| Johnson & Johnson(3 entities) | 16 | $701 |
| Linkbio Corp | 3 | $619 |
| Conformis, Inc. | 3 | $453 |
| Stryker | 4 | $187 |
| Medical Device Business Services, Inc. | 1 | $180 |
| Linvatec Corporation | 1 | $138 |
| DJO, LLC | 1 | $84 |
| Pacira Pharmaceuticals Incorporated | 4 | $80 |
| Smith+Nephew | 2 | $55 |
| Straumann USA LLC | 2 | $35 |
| Convatec Inc. | 1 | $24 |
| Pacira Therapeutics, Inc. | 1 | $21 |
| Encore Medical, LP | 1 | $17 |
| KCI USA, Inc. | 1 | $13 |
| SPR Therapeutics, Inc | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Avenir$984
- Oxford$705
- Persona$473
- Hip, Identity CR$157
- iTotal CR, iTotal PS, iUni, Hip System$149
- iTotal, Identity CR$147
- iTotal Identity PS$147
- BioBrace 23mm$138
- G7$116
- TFN ADVANCED$112
- mymobility Platform$104
How this compares
$8,361 in reported general payments places this provider in the 70th percentile of 319 orthopaedic surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 463 | $6,747 |
| Tramadol Hcl | 399 | $2,976 |
| Pregabalin | 147 | $2,947 |
| Ondansetron OdtOndansetron | 153 | $2,862 |
| Oxycodone Hcl | 248 | $1,198 |
| Cefdinir | 30 | $498 |
| Methylprednisolone | 48 | $361 |
| Ondansetron Hcl | 34 | $323 |
| Diclofenac Sodium | 23 | $301 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $196 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 42 | $192 |
| Meloxicam | 28 | $140 |
| Doxycycline Hyclate | 12 | $114 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Birmingham
- Jeffrey DugasBirmingham$11.7M
- Benton EmblomBirmingham$3.1M
- Herrick SiegelBirmingham$1.3M
- Kenneth MooreBirmingham$342K
- Jeffrey DavisBirmingham$293K
- Joseph SherrillBirmingham$221K
- Jonathan QuadeBirmingham$219K
- Ginger BryantBirmingham$209K
- Marcus RothermichBirmingham$207K
- Richard SandersBirmingham$179K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.